Dostarlimab (Anti-PDCD1 / PD-1 / CD279)
Product Specifications
CAS Number
2022215-59-2
Target
PD-1/PD-L1
Applications
Apoptosis
Additionnal Information
Dostarlimab (Anti-PDCD1 / PD-1 / CD279) is a humanized monoclonal antibody directed against the negative immunoregulatory human cell surface receptor programmed cell death 1 ((PD-1 programmed death-1), with potential immune checkpoint inhibitory and antineoplastic activities. MW : 144.18 KD.
Storage Conditions
Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
K1368708 1.0 µg DNA
MUM1L1 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 3)
Sign In for Pricing
View Details 
MBS1401000 Inquire
Recombinant Macaca fascicularis Leucine-rich repeat-containing protein 48 (LRRC48), partial
Sign In for Pricing
View Details ARP69293_P050-FITC 100 µL
CARNMT1 Antibody - middle region : FITC (ARP69293_P050-FITC)
Sign In for Pricing
View Details